| Name | Title | Contact Details |
|---|---|---|
Rama Donepudi |
Chief Information Officer (CIO), Global Nutrition at Reckitt | Profile |
Filippo Catalano |
Chief Information and Digitisation Officer | Profile |
Magdalena Skorupa |
Director of Cyber Risk and Compliance | Profile |
At Hyperice, our mission is to provide everyone with the most innovative technology in accelerating recovery time, preventing injury, and enhancing the body`s ability to move more efficiently. All Hyperice products are developed and tested to meet the standards of the world`s best athletes.
Wesleyan Nursing Home is a Georgetown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DJO Surgical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PhotoMedex is a leader in the dermatology market, committed to the Science of Skin Health in disease management and skin rejuvenation. We focus our efforts where we can make meaningful differences in dermatological applications for psoriasis and vitiligo, therapeutic skin care and LED therapy for acne and photodamage. Our Purpose, to provide branded dermatological solutions of superior value to improve patients` lives now and into the future, is our common goal and leads our thinking. The results of which will be realized in physicians and patients rewarding us with winning sales, profit and equity generation. Our commitment to safety and efficacy is reflected in our dedication to scientific development and has led to a broad range of FDA clearances. XTRAC was the first FDA market-cleared excimer laser system for the treatment of dermatological applications, including psoriasis and vitiligo. The Omnilux LED system carries FDA clearances for skin rejuvenation, acne and pain management. Neova, the science of skin care, holds dozens of patents on its clinically proven Copper Peptide technology for skin health, hair care and wound care.
Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.